7 Pharmacists should be diligent in staying up to date with emerging benefits of GLP-1 RAs, especially in new indications such as PD, and follow releases of new clinical data that more confidently highlight the role of GLP-1 RAs in PD
H.GonalvesL
When clinical trial titration data is not available, which is common for peptides like BPC-157 and TB-500 that have not completed human dosing studies, we use the most widely cited community protocols from credible sources and clearly label the evidence tier
Keeping these levels lower is critical not only to good blood sugar control, but to preventing the long-term effects of diabetes including cardiovascular disease, nerve damage, kidney injury, and eye problems
These changes create a foundation that minimizes gastrointestinal distress once the medication kicks in
Our data show that addition of A 40 oligomers increased cytotoxicity in astrocytes after a 24-h incubation